VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics

Overview of attention for article published in PLOS ONE, October 2012

Altmetric Badge

Mentioned by

twitter: 1 X user
patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity

Application US-9617225-B2

United States of America